ArticleClinical and molecular hepatology2025
Correspondence to editorial on "Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial".
Woo Hyun Paik et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.